Загрузка...
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
Lung cancer patients are at heightened risk for developing COVID-19 infection as well as complications due to multiple risk factors such as underlying malignancy, anti-cancer treatment induced immunosuppression, additional comorbidities and history of smoking. Recent literatures have reported a sign...
Сохранить в:
| Опубликовано в: : | Arch Med Res |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
IMSS. Published by Elsevier Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7670900/ https://ncbi.nlm.nih.gov/pubmed/33257051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.arcmed.2020.11.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|